Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Explore conversion timing for a two-earner couple, including tax impact, income thresholds, and optimal years to convert for long-term growth.
18,272 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A new Federal Reserve chair is on the horizon, and markets are keen to know what it means for loans, mortgages, and i...
Ford's China negotiations could redefine its growth trajectory. This article explains the real reason investors shoul...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
Bitcoin trades below $65k, yet Polymarket participants are betting on a $150k price by year-end 2026. This article ex...
If you want safe dividend income, you don’t have to chase flashy yields. This guide lays out a practical plan to buil...
BlueStem Wealth Partners disclosed a substantial new stake in VictoryShares Short-Term Bond ETF (USTB) during the lat...
American Express will relocate its headquarters to the World Trade Center’s final office tower, a milestone in Lower ...
Prediction markets offer probabilities, not guarantees. This article explains what polymarket says bitcoin just 3% od...
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
When a high-profile buyout falls short of expectations, stocks swing and traders scramble for context. This deep dive...